Jian Zhou, Hui-Chuan Sun, Zheng Wang, W. Cong, Jian-hua Wang, M. Zeng, Jiamei Yang, P. Bie, Lian-Xin Liu, T. Wen, G. Han, Maoqiang Wang, R. Liu, Ligong Lu, Zheng-Gang Ren, Minshan Chen, Z. Zeng, P. Liang, C. Liang, Min Chen, Fuhua Yan, Wen-ping Wang, Yuan Ji, W. Cheng, C. Dai, W. Jia, Yaming Li, Ye‐Xiong Li, Jun Liang, Tianshu Liu, G. Lv, Y. Mao, W. Ren, Hong-Cheng Shi, Wen-tao Wang, Xiao-Ying Wang, B. Xing, Jian‐ming Xu, Jian-yong Yang, Yefa Yang, S. Ye, Zhengyu Yin, Boheng Zhang, Shui-Jun Zhang, Weiping Zhou, Jiye Zhu, Rong Liu, Yinghong Shi, Yong-Sheng Xiao, Z. Dai, G. Teng, J. Cai, Weilin Wang, Jia-hong Dong, Qiang Li, F. Shen, S. Qin, Jia Fan
2018.6.14Liver Cancer
tlooto Summary
A guideline on the surveillance, diagnosis, staging, and treatment of HCC occurring in China is presented, and recommendations regarding patients with HCC in China are made to ensure optimum patient outcomes.
Abstract
Background: Hepatocellular carcinoma (HCC) (about 85–90% of primary liver cancer) is particularly prevalent in China because of the high prevalence of chronic hepatitis B infection. HCC is the fourth most common malignancy and the third leading cause of tumor-related deaths in China. It poses a significant threat to the life and health of Chinese people. Summary: This guideline presents official recommendations of the National Health and Family Planning Commission of the People’s Republic of China on the surveillance, diagnosis, staging, and treatment of HCC occurring in China. The guideline was written by more than 50 experts in the field of HCC in China (including liver surgeons, medical oncologists, hepatologists, interventional radiologists, and diagnostic radiologists) on the basis of recent evidence and expert opinions, balance of benefits and harms, cost-benefit strategies, and other clinical considerations. Key Messages: The guideline presents the Chinese staging system, and recommendations regarding patients with HCC in China to ensure optimum patient outcomes.
Citation format
ZHOU, Jian, et al. Guidelines for diagnosis and treatment of primary liver cancer in China (2017 edition). Liver Cancer, 2018, 7: 235–260.